Unlike glutathione tablets and capsules which may cause some gastric discomfort for those with a sensitive stomach, liposomal glutathione is generally free from side effects
Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release
Espinoza SE, Guo H, Fedarko N, DeZern A, Fried LP, Xue QL, et al
Emerging evidence also highlights the importance of dietary modifications to mitigate these risks
Now, Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes
Most published work is in rodent models